GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Rhinomed Ltd (ASX:RNO) » Definitions » PB Ratio
中文

Rhinomed (ASX:RNO) PB Ratio

: (As of Today)
View and export this data going back to 2007. Start your Free Trial

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-04-23), Rhinomed's share price is A$0.04. Rhinomed's Book Value per Share for the quarter that ended in Jun. 2023 was A$-0.02. Hence, Rhinomed's PB Ratio of today is .

The historical rank and industry rank for Rhinomed's PB Ratio or its related term are showing as below:

During the past 13 years, Rhinomed's highest PB Ratio was 19.87. The lowest was 0.14. And the median was 2.84.

ASX:RNO's PB Ratio is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 2.185
* Ranked among companies with meaningful PB Ratio only.

During the past 12 months, Rhinomed's average Book Value Per Share Growth Rate was -222.20% per year.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Rhinomed was 34.30% per year. The lowest was -53.10% per year. And the median was -22.60% per year.

Back to Basics: PB Ratio


Rhinomed PB Ratio Historical Data

The historical data trend for Rhinomed's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rhinomed Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.98 1.63 8.10 6.39 -

Rhinomed Semi-Annual Data
Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.10 25.66 6.39 115.00 -

Competitive Comparison

For the Medical Devices subindustry, Rhinomed's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Rhinomed PB Ratio Distribution

For the Medical Devices & Instruments industry and Healthcare sector, Rhinomed's PB Ratio distribution charts can be found below:

* The bar in red indicates where Rhinomed's PB Ratio falls into.



Rhinomed PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Rhinomed's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Jun. 2023)
=0.04/-0.022
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Rhinomed  (ASX:RNO) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Rhinomed PB Ratio Related Terms

Thank you for viewing the detailed overview of Rhinomed's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Rhinomed (ASX:RNO) Business Description

Traded in Other Exchanges
Address
132 Gwynne Street, Level 1, Cremorne, VIC, AUS, 3121
Rhinomed Ltd is a medical technology company, with a patented nasal technology platform. It is engaged in the research, development and commercialization of consumer and medical devices including nasal, respiratory and nasal drug delivery technologies. It operates in one segment which is the identification, acquisition, and commercialization of late-stage consumer therapeutic and medical delivery technologies. The products of the company involve Rhinoswab, Mute, Turbine and Rhinoswab Junior. It operates geographically within North, Central, and South America, Asia-Pacific, Europe, Middle East, and Africa. The company earns majority of its revenue from Asia-Pacific.

Rhinomed (ASX:RNO) Headlines

No Headlines